Literature DB >> 18688572

Radiobiologic response of medulloblastoma cell lines: involvement of beta-catenin?

Roberta Salaroli1, Tiziano Di Tomaso, Alice Ronchi, Claudio Ceccarelli, Silvia Cammelli, Alessandra Cappellini, Giuseppe Nicola Martinelli, Enza Barbieri, Felice Giangaspero, Giovanna Cenacchi.   

Abstract

Medulloblastoma (MB) is the most common brain malignancy in children. Whole neural axis irradiation is the treatment of choice, but it often results in long-term neurocognitive and developmental impairment. Only insights into MB biology will lead to improved therapeutic outcome. Wingless (WNT) signalling deregulation occurs in up to 25% of sporadic tumors, but the specific role of nuclear beta-catenin and its involvement in the radioresponse remains unsettled. Therefore we studied the gamma-radiation response of two MB cell lines from cellular and molecular points of view. Our data show that the p53 wild-type cell line is more sensitive to ionizing radiations (IR) than the p53 mutated line, but apoptosis is also induced in p53-mutated cells, suggesting an alternative p53-independent mechanism. In addition, this study is the first to demonstrate that gamma-rays trigger the WNT system in our in vitro models. Further studies are required to test if this could explain the radiosensitivity of MB and the favorable prognostic value of nuclear beta-catenin in this tumor.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18688572     DOI: 10.1007/s11060-008-9659-5

Source DB:  PubMed          Journal:  J Neurooncol        ISSN: 0167-594X            Impact factor:   4.130


  53 in total

1.  The nonsteroidal anti-inflammatory drugs aspirin and indomethacin attenuate beta-catenin/TCF-4 signaling.

Authors:  S Dihlmann; A Siermann; M von Knebel Doeberitz
Journal:  Oncogene       Date:  2001-02-01       Impact factor: 9.867

2.  A senescence-like phenotype distinguishes tumor cells that undergo terminal proliferation arrest after exposure to anticancer agents.

Authors:  B D Chang; E V Broude; M Dokmanovic; H Zhu; A Ruth; Y Xuan; E S Kandel; E Lausch; K Christov; I B Roninson
Journal:  Cancer Res       Date:  1999-08-01       Impact factor: 12.701

3.  Deregulated beta-catenin induces a p53- and ARF-dependent growth arrest and cooperates with Ras in transformation.

Authors:  A Damalas; S Kahan; M Shtutman; A Ben-Ze'ev; M Oren
Journal:  EMBO J       Date:  2001-09-03       Impact factor: 11.598

Review 4.  Pathogenesis of medulloblastoma and current treatment outlook.

Authors:  Jaroslaw Jozwiak; Wieslawa Grajkowska; Pawel Wlodarski
Journal:  Med Res Rev       Date:  2007-11       Impact factor: 12.944

Review 5.  The WHO classification of tumors of the nervous system.

Authors:  Paul Kleihues; David N Louis; Bernd W Scheithauer; Lucy B Rorke; Guido Reifenberger; Peter C Burger; Webster K Cavenee
Journal:  J Neuropathol Exp Neurol       Date:  2002-03       Impact factor: 3.685

6.  Overexpression of components of the Frizzled-Dishevelled cascade results in apoptotic cell death, mediated by beta-catenin.

Authors:  M E van Gijn; F Snel; J P Cleutjens; J F Smits; W M Blankesteijn
Journal:  Exp Cell Res       Date:  2001-04-15       Impact factor: 3.905

Review 7.  Medulloblastoma: developmental mechanisms out of control.

Authors:  Silvia Marino
Journal:  Trends Mol Med       Date:  2005-01       Impact factor: 11.951

8.  Neuropsychological sequelae of the treatment of children with medulloblastoma.

Authors:  M Dennis; B J Spiegler; C R Hetherington; M L Greenberg
Journal:  J Neurooncol       Date:  1996-07       Impact factor: 4.130

9.  Beta-catenin regulation during the cell cycle: implications in G2/M and apoptosis.

Authors:  David Olmeda; Susanna Castel; Senén Vilaró; Amparo Cano
Journal:  Mol Biol Cell       Date:  2003-04-04       Impact factor: 4.138

10.  Radiation-induced gene expression in human subcutaneous fibroblasts is predictive of radiation-induced fibrosis.

Authors:  Olaug Kristin Rødningen; Anne-Lise Børresen-Dale; Jan Alsner; Trevor Hastie; Jens Overgaard
Journal:  Radiother Oncol       Date:  2007-10-25       Impact factor: 6.280

View more
  7 in total

Review 1.  Childhood medulloblastoma: current status of biology and treatment.

Authors:  Laura J Klesse; Daniel C Bowers
Journal:  CNS Drugs       Date:  2010-04       Impact factor: 5.749

2.  Wnt activation affects proliferation, invasiveness and radiosensitivity in medulloblastoma.

Authors:  Roberta Salaroli; Alice Ronchi; Francesca Romana Buttarelli; Filippo Cortesi; Valeria Marchese; Elena Della Bella; Cristiano Renna; Caterina Baldi; Felice Giangaspero; Giovanna Cenacchi
Journal:  J Neurooncol       Date:  2014-09-28       Impact factor: 4.130

3.  The Roles of SIRT1 in Cancer.

Authors:  Zhenghong Lin; Deyu Fang
Journal:  Genes Cancer       Date:  2013-03

4.  XAV939-mediated ARTD activity inhibition in human MB cell lines.

Authors:  Cristiano Renna; Roberta Salaroli; Claudia Cocchi; Giovanna Cenacchi
Journal:  PLoS One       Date:  2015-04-02       Impact factor: 3.240

5.  WNT activation by lithium abrogates TP53 mutation associated radiation resistance in medulloblastoma.

Authors:  Nataliya Zhukova; Vijay Ramaswamy; Marc Remke; Dianna C Martin; Pedro Castelo-Branco; Cindy H Zhang; Michael Fraser; Ken Tse; Raymond Poon; David J H Shih; Berivan Baskin; Peter N Ray; Eric Bouffet; Peter Dirks; Andre O von Bueren; Elke Pfaff; Andrey Korshunov; David T W Jones; Paul A Northcott; Marcel Kool; Trevor J Pugh; Scott L Pomeroy; Yoon-Jae Cho; Torsten Pietsch; Marco Gessi; Stefan Rutkowski; Laszlo Bognár; Byung-Kyu Cho; Charles G Eberhart; Cecile Faure Conter; Maryam Fouladi; Pim J French; Wieslawa A Grajkowska; Nalin Gupta; Peter Hauser; Nada Jabado; Alexandre Vasiljevic; Shin Jung; Seung-Ki Kim; Almos Klekner; Toshihiro Kumabe; Boleslaw Lach; Jeffrey R Leonard; Linda M Liau; Luca Massimi; Ian F Pollack; Young Shin Ra; Joshua B Rubin; Erwin G Van Meir; Kyu-Chang Wang; William A Weiss; Karel Zitterbart; Robert G Bristow; Benjamin Alman; Cynthia E Hawkins; David Malkin; Steven C Clifford; Stefan M Pfister; Michael D Taylor; Uri Tabori
Journal:  Acta Neuropathol Commun       Date:  2014-12-24       Impact factor: 7.801

6.  Expression and prognostic value of SFRP1 and β-catenin in patients with glioblastoma.

Authors:  Liang Chang; Xuhui Lei; Y U Qin; Guangchun Zeng; Xuexin Zhang; Hua Jin; Chao Wang; Xin Wang; Jun Su
Journal:  Oncol Lett       Date:  2015-11-05       Impact factor: 2.967

7.  An investigation of WNT pathway activation and association with survival in central nervous system primitive neuroectodermal tumours (CNS PNET).

Authors:  H A Rogers; S Miller; J Lowe; M-A Brundler; B Coyle; R G Grundy
Journal:  Br J Cancer       Date:  2009-03-17       Impact factor: 7.640

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.